序号 | 专利名 | 申请号 | 申请日 | 公开(公告)号 | 公开(公告)日 | 发明人 |
---|---|---|---|---|---|---|
1 | Composition and method for treating premenstrual syndrome | US27147 | 1998-02-20 | US5968518A | 1999-10-19 | Laurie Pike |
An herbal composition is disclosed comprising as active ingredients chickweed, yarrow, wormwood, motherwort, pennyroyal, and dandelion in a vehicle of olive-oil and beeswax. The composition alleviates cramps, aches and pains, such as those associated with premenstrual syndrome. | ||||||
2 | Biologically active extracts from Cerastium viscusum L. (Coryophyllaceae) Mississippi and method of obtaining same | US467767 | 1983-02-18 | US4454124A | 1984-06-12 | Sidney M. Hecht |
This invention provides an extract from the plant Cerastium viscusum L. (Coryophyllaceae) Mississippi and a method of obtaining same. The extract is obtained by subjecting the plant to a series of extraction steps with a plurality of solvents having different polarities. In each extraction step, the solvent used has a polarity higher than that used in the preceding extraction step. All extraction steps are conducted at room temperature. The extracts have been found to possess biological activity. | ||||||
3 | Lectins and antiretroviral drugs containing the lectins as active ingredient | US207836 | 1988-06-17 | US4985543A | 1991-01-15 | Norifumi Sugita; Koichi Niimura; Yoshiharu Oguchi; Kunitaka Hirose; Kenichi Matsunaga; Minoru Oohara; Shigeaki Muto; Junji Kakuchi; Takao Furusho; Chikao Yoshikumi; Masaaki Takahashi |
Disclosed herein are lectins extracted form a plant of the class Dicotyledoneae and an antiretoviral drug comprising as an active ingredient an effective amount of the lectins. | ||||||
4 | Procedure for manufacturing saponine extract | US104792 | 1979-12-18 | US4350688A | 1982-09-21 | Hans B. Schmittmann |
A saponine extract product which is a granulate in pellet form, the granules being pourable and having low hygroscopicity. A process for producing a pourable granular saponine extract product of low hygroscopicity comprising granulizing a saponine extract in a fluidized bed. | ||||||
5 | moseley | US74118D | US74118A | 1868-02-04 | ||
6 | Pharmaceutical composition for prophylaxis and treatment of premature ejaculation | US304855 | 1994-09-13 | US5587167A | 1996-12-24 | Hyung K. Choi; Zhong C. Xin |
The present invention relates to an ointment composition for prophylaxis and treatment of premature ejaculation in a male patient and more particularly to a composition for applying to the glans penis, which contains the alcohol and/or aqueous extracts of ginseng radix, angelicae gigantis radix, broomrape, cassiae cortex, asiasari radix and bufonis venenum as the essential galenic components and, if necessary, one or more additional components selected from the extracts of xanthoxyli fructus, cnidium fructus, caryophylli flos and moschus. | ||||||
7 | Method of treating skin virus infections | US116368 | 1987-11-02 | US4986985A | 1991-01-22 | Shlomo Grossman; Michael Albeck |
Water-soluble plant extracts, and fractions separated from such extracts by chromatography, which provide an antioxidant effect when applied to the skin, are utilized in a method of treating virus skin infections and resultant skin conditions, e.g. warts. Preferred plants are Trifolium, Medicago, Nicotiana, Zea, Pennisetum, Algae and Allium, and members of the order Chenopodiales such as the families Chenopodiaceae and Aizoaceae. | ||||||
8 | Lipoglycosides and process of extracting same | US522270 | 1983-08-11 | US4590264A | 1986-05-20 | Sidney M. Hecht; David G. Lynn; Kalakota S. Reddy |
This invention provides novel lipoglycosides having the structural formula: ##STR1## wherein R.sub.1 and R.sub.2 are different and are selected from the group consisting of hydrogen and ##STR2## The lipoglycosides have antitumor properties. | ||||||
9 | 脂肪肝治療用組成物 | JP2016224986 | 2016-11-18 | JP2018080142A | 2018-05-24 | 劉 大器; 那須 正則 |
【課題】脂肪肝、特に従来の食事療法、運動療法及び/又は西洋医学的治療によっては改善が見られない脂肪肝であっても有意に改善できる脂肪肝治療用組成物(漢方処方)を提供する。 【解決手段】人参(にんじん)、白朮(びゃくじゅつ)、山▲ざ▼(さんざ)、沢瀉(たくしゃ)及び決明子(けつめいし)のエキスを含む脂肪肝治療用組成物。 【選択図】なし |
||||||
10 | 漢方薬組成物の、肉体疲労の緩和及び予防治療のための健康食品や医薬品の調製への応用 | JP2016083531 | 2016-04-19 | JP6305457B2 | 2018-04-04 | ▲じょぉん▼ 虹光; 易 ▲敏▼之; ▲盧▼ 建中; 李 ▲い▼光; ▲ま▼ 莉; 郭 勇金; ▲しゅい▼ ▲じん▼珍; ▲呂▼ 毅斌; ▲やお▼ ▲梅▼香 |
11 | アルコキシル化天然ワックスを有する眼用組成物 | JP2014558739 | 2013-01-10 | JP2015509495A | 2015-03-30 | シア,アルニン; フリードマン,クリスタ |
アルコキシル化ラノリンおよびアルコキシル化ホホバからなる群より選択されるアルコキシル化天然ワックスを0.005質量%から2.0質量%含む眼用組成物、およびその眼用組成物で、ドライアイ症候群と診断された患者を治療する方法、またはコンタクトレンズを洗浄し、殺菌する方法が開示されている。 | ||||||
12 | ACTIVE INGREDIENT STIMULATING TYPE 2 OR TYPE 3 HUMAN β-DEFENSIN AND COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH ACTIVE INGREDIENT | JP2012198441 | 2012-09-10 | JP2012250992A | 2012-12-20 | PERRIER ERIC; GUEZENNEC ANNE; PERNET INGRID; REYMERNIER CORINNE; GUESNET JOELLE |
PROBLEM TO BE SOLVED: To provide an active ingredient capable of stimulating direct or indirect expression of type 2 and/or type 3 human β-defensins.SOLUTION: There are provided an active ingredient capable of stimulating direct or indirect expression of type 2 and/or type 3 human β-defensins, characterized in that the active ingredient does not cause any inflammatory, irritation or intolerance reactions; and a screening method for the selection of such active ingredients. The invention is applicable to the preparation of a cosmetic composition and a pharmaceutical composition containing the active ingredients. | ||||||
13 | Active ingredient stimulating type 2 or type 3 human beta-defensin and cosmetic and pharmaceutical compositions containing such active ingredient | JP2007208376 | 2007-08-09 | JP2008019264A | 2008-01-31 | PERRIER ERIC; GUEZENNEC ANNE; PERNET INGRID; REYMERNIER CORINNE; GUESNET JOELLE |
PROBLEM TO BE SOLVED: To provide an active ingredient capable of stimulating direct or indirect expression of type 2 and/or type 3 human beta-defensins. SOLUTION: The active ingredient capable of stimulating direct or indirect expression of type 2 and/or type 3 human beta-defensins without causing any inflammatory, irritation or hypersensitive reaction is chosen from (i) an extract chosen from the group consisting of a quinoa extract, a boldo extract and a mixture of the quinoa and boldo extracts, (ii) jasmonic acid and (iii) mixtures thereof. A cosmetic or pharmaceutical composition containing the active ingredient at a concentration ranging from 0.001 wt.% to 20 wt.% exerts a bactericidal or antifungal property. A screening method for the selection of such active ingredient is also provided. COPYRIGHT: (C)2008,JPO&INPIT | ||||||
14 | Herbal composition for prostate symptoms | JP2006500765 | 2004-01-16 | JP2006515615A | 2006-06-01 | ヨン クォク,クーン; リー,ヒレン |
方法および組成物が、前立腺炎、良性前立腺肥大および前立腺ガン腫を含む前立腺の障害の防止又は治療、およびその改良を開示している。 方法は、以下の薬草成分や他の成分を含む物質の組成物を投与することを含み、薬草成分およびその他の成分としては、Radix Asparagi,Radix Angelicae Pubescentis,Radix Trichosanthis,Radix Scutteariae,Radix Angelicae Sinensis;Radix Dipsaci,Cortex Eucommiae,Medulla Junci,Rhizoma Anemarrhenae,Caulis Akebiae,Herba Dianthi,Semen Plataginis,Cortex Phellodendri(fried),Radix et Rhizoma Rhei,Rhizoma seu Radix Notopterygii,Olibanum,Fructus Gardeiae,Radix Astragali seu Hedysari,Rhizomz Cimicifugae,Radix Bupleuri,Myrrha,Gypsum Fibrosun,Radix Rehamanniae(crude),Folium Pyrrosiae,Rhizoma Acori Graminei,Rhizoma Dioscoreae Hypoglaucae,Radix Linderae,Herba Cistanche,Radix Paeoniae Rubra,Rhizoma Dioscoreae,Semen Euryales,Cortex Mouton,Polyporus Umbellatus,Radix Rehmanniae Praeparata,Medulla Tetrapanacis,Semen Coicis,Fructus Horedi Germinatus(Poria),Radix Aconiti Praeparata,Rhizoma Alismatis,Cortex Cinnamomi,Herba Asari,Radix Glycyrrhizae,Stigma Maydis,and Phaseolus Radiatus L、そして所望によるGanoderma Lucidumがあげられる。 | ||||||
15 | Health food | JP2000397334 | 2000-12-27 | JP2002204672A | 2002-07-23 | DAICHO TAKAO |
PROBLEM TO BE SOLVED: To provide an extremely effective health food having effect close to the one which Chinese traditional medical science has achieved. SOLUTION: This health food contains a cholic acid, particularly, a cholic acid and isoflavone and/or isoflavone glucoside. COPYRIGHT: (C)2002,JPO | ||||||
16 | Premature ejaculation prophylactic or therapeutic pharmaceutical composition | JP22053194 | 1994-09-14 | JP2531936B2 | 1996-09-04 | CHUE HYONGU GI; SHIN JONGU CHONGU |
17 | Pharmaceutical composition for prevention and treatment of premature ejaculation | JP22053194 | 1994-09-14 | JPH07300423A | 1995-11-14 | CHIYUE HIYONGU GI; SHIN JIYONGU CHIYONGU |
PURPOSE: To provide a pharmaceutical composition that prevents and treat premature ejaculation and is useful for erection insufficiency. CONSTITUTION: This pharmaceutical composition for prevention and treatment of premature ejaculation contains active component of ginseng radix, angelicae gigantis radix, cistanchis herba, broomrape, cassiae cortex, asiasary radix, and bufonis venemum as the essential galenic components and, if necessary, one or more of xanthoxyli fructus, cnidium fructus, caryophylli flos and moschus. The contents of these components are 60-140 pts.wt. of ginseng radix, 60-140 pts.wt. of angelicae gigantis radix, 60-140 pts.wt. of cistanchis herba, 10-30 pts.wt. of cassiae cortex, 10-30 pts.wt. of asiasary radix, and 15-25 pts.wt. of bufonis venemum as the essential galenic components and, if necessary, 40-70 pts.wt. of xanthoxyli fructus, 60-140 pts.wt. of cnidium fructus, 10-30 pts.wt. of caryophylli flos and 5-15 pts.wt. of moschus. These active components are extracted with water or alcohol where cnidium fructus is extracted only with water. The preparation is used in the forms of ointment, suspension, gel, spray or solution. | ||||||
18 | 瓦草5環性トリテルペンサポニン類化合物抗腫瘍の薬物用途 | JP2017518396 | 2015-06-15 | JP6389958B2 | 2018-09-12 | 王 学勇; 趙 保勝 |
19 | 脂肪肝治療用組成物 | JP2016224986 | 2016-11-18 | JP6145552B1 | 2017-06-14 | 劉 大器; 那須 正則 |
【課題】脂肪肝、特に従来の食事療法、運動療法及び/又は西洋医学的治療によっては改善が見られない脂肪肝であっても有意に改善できる脂肪肝治療用組成物(漢方処方)を提供する。 【解決手段】人参(にんじん)、白朮(びゃくじゅつ)、山▲ざ▼(さんざ)、沢瀉(たくしゃ)及び決明子(けつめいし)のエキスを含む脂肪肝治療用組成物。 【選択図】なし |
||||||
20 | 上気道の疾患およびインフルエンザ症候群を治療するための組成物 | JP2011512001 | 2009-05-25 | JP5992171B2 | 2016-09-14 | ボンバルデッリ、 エッツィオ |